melanotan 2 reduce moles Figure 4 from Changes of melanocytic lesions inducedby injections and sun bed use ina teenage patient with FAMMM syndrome Melanotan II | Melanocortin Agonist

Blue nevus is characterized by a variety of histologic subtypes, although most are classified as either common or cellular (14)

Development of new nevi (moles) and changes to pre-existing ones Several researchers have documented cases where MT-II administration caused the development of new pigmented nevi or pre-existing nevi to grow and darken in color

Squamous cell carcinoma may arise in about 5% of Bowens disease cases (42)

Although severe reactions are rare, the absence of long-term studies means that Melanotan 1 should be treated with caution and under the supervision of health professionals

Research shows it increases dopaminergic activity in the medial preoptic area of the hypothalamus by activating melanocortin-4 receptors (MC4R) and melanocortin-3 receptors (MC3R)